Acceleron Pharma
(XLRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -166,030 | -124,858 | -118,871 | -108,454 | -57,014 |
| Depreciation Amortization | 3,845 | 3,941 | 3,747 | 2,825 | 1,676 |
| Accounts receivable | -17,554 | -1,508 | -3,470 | -336 | 394 |
| Accounts payable and accrued liabilities | 5,830 | 1,876 | -673 | -504 | 644 |
| Other Working Capital | 243 | 3,990 | -4,560 | -331 | -494 |
| Other Operating Activity | 43,339 | 22,755 | 29,121 | 30,256 | 10,249 |
| Operating Cash Flow | $-130,327 | $-93,804 | $-94,706 | $-76,544 | $-44,545 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 268,027 | 327,134 | 199,087 | N/A | 112,889 |
| PPE Investments | -4,203 | -3,287 | -2,590 | -4,396 | -3,380 |
| Purchase Of Investment | -238,228 | -395,138 | -73,570 | -179,935 | -218,314 |
| Sale Of Investment | N/A | N/A | N/A | 119,965 | N/A |
| Investing Cash Flow | $25,596 | $-71,291 | $122,927 | $-64,366 | $-108,805 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | 0 | 0 | -139 | N/A | N/A |
| Common Stock Issued | 492,414 | 248,130 | 0 | 215,802 | 146,667 |
| Other Financing Activity | 45,592 | 10,590 | 16,285 | 4,494 | 0 |
| Financing Cash Flow | $538,006 | $258,720 | $16,146 | $220,296 | $146,667 |
| Beginning Cash Position | 239,274 | 145,649 | 101,282 | 21,896 | 28,579 |
| End Cash Position | 672,549 | 239,274 | 145,649 | 101,282 | 21,896 |
| Net Cash Flow | $433,275 | $93,625 | $44,367 | $79,386 | $-6,683 |
| Free Cash Flow | |||||
| Operating Cash Flow | -130,327 | -93,804 | -94,706 | -76,544 | -44,545 |
| Capital Expenditure | -4,203 | -3,287 | -2,590 | -4,396 | -3,380 |
| Free Cash Flow | -134,530 | -97,091 | -97,296 | -80,940 | -47,925 |